Conmed Corp
CNMD40.770USD
+0.600+1.49%
終値 12/26, 16:00（ET）15分遅れの株価
1.26B時価総額
19.71直近12ヶ月PER
詳細情報 Conmed Corp 企業名
CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Conmed Corpの企業情報
企業コードCNMD
会社名Conmed Corp
上場日Jul 23, 1987
最高経営責任者「CEO」Beyer (Patrick J)
従業員数3900
証券種類Ordinary Share
決算期末Jul 23
本社所在地11311 Concept Boulevard
都市LARGO
証券取引所NASDAQ OMX NASDAQ Basic NYSE
国United States of America
郵便番号33773
電話番号17272142974
ウェブサイトhttps://www.conmed.com/
企業コードCNMD
上場日Jul 23, 1987
最高経営責任者「CEO」Beyer (Patrick J)
Conmed Corpの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.24K
+2.86%
Mr. Stephan Epinette
Mr. Stephan Epinette
Vice President and General Manager, International
Vice President and General Manager, International
15.51K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
+4.97%
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
5.79K
+9.03%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
+5.01%
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
2.89K
--
Mr. Brent Lalomia
Mr. Brent Lalomia
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
1.13K
+18.20%
Mr. Kim Kelderman
Mr. Kim Kelderman
Independent Director
Independent Director
--
--
Mr. Richard Glaze
Mr. Richard Glaze
Chief Information Officer
Chief Information Officer
--
-100.00%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.24K
+2.86%
Mr. Stephan Epinette
Mr. Stephan Epinette
Vice President and General Manager, International
Vice President and General Manager, International
15.51K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
+4.97%
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
5.79K
+9.03%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
+5.01%
収益内訳
通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
General Surgery
201.61M
58.89%
Orthopedic Surgery
140.73M
41.11%
地域別USD
会社名
収益
比率
United States
190.61M
55.68%
Europe & Middle East & Africa
63.92M
18.67%
Asia Pacific
42.07M
12.29%
Americas (excluding the United States)
31.88M
9.31%
事業別
地域別
事業別USD
会社名
収益
比率
General Surgery
201.61M
58.89%
Orthopedic Surgery
140.73M
41.11%
株主
更新時刻: Sun, Nov 30
更新時刻: Sun, Nov 30
株主統計
種類
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
13.90%
The Vanguard Group, Inc.
11.63%
EARNEST Partners, LLC
9.04%
Fuller & Thaler Asset Management Inc.
5.60%
Westwood Management Corp. (Texas)
4.29%
他の
55.53%
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
13.90%
The Vanguard Group, Inc.
11.63%
EARNEST Partners, LLC
9.04%
Fuller & Thaler Asset Management Inc.
5.60%
Westwood Management Corp. (Texas)
4.29%
他の
55.53%
種類
株主統計
比率
Investment Advisor
55.01%
Investment Advisor/Hedge Fund
46.65%
Hedge Fund
7.01%
Research Firm
2.89%
Pension Fund
1.93%
Bank and Trust
0.68%
Individual Investor
0.59%
Sovereign Wealth Fund
0.06%
Insurance Company
0.04%
機関投資家保有株
更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
638
36.30M
136.51%
+226.00
2025Q3
655
36.31M
137.32%
-1.03M
2025Q2
649
37.27M
138.33%
-832.15K
2025Q1
642
38.16M
137.89%
-4.49M
2024Q4
628
38.56M
133.23%
+1.56M
2024Q3
620
37.00M
134.64%
-1.79M
2024Q2
640
38.79M
129.72%
+1.14M
2024Q1
637
37.49M
133.32%
-3.56M
2023Q4
623
39.15M
131.18%
+747.69K
2023Q3
604
38.42M
132.14%
+127.38K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
BlackRock Institutional Trust Company, N.A.
4.43M
14.3%
-133.34K
-2.92%
Jun 30, 2025
The Vanguard Group, Inc.
3.54M
11.44%
+42.41K
+1.21%
Jun 30, 2025
EARNEST Partners, LLC
2.83M
9.14%
+30.22K
+1.08%
Jun 30, 2025
Fuller & Thaler Asset Management Inc.
1.74M
5.62%
+566.60K
+48.26%
Jun 30, 2025
Westwood Management Corp. (Texas)
1.24M
4%
-484.00
-0.04%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.08M
3.5%
+184.21K
+20.50%
Jun 30, 2025
State Street Investment Management (US)
1.29M
4.18%
-8.83K
-0.68%
Jun 30, 2025
Managed Account Advisors LLC
1.38M
4.47%
+103.77K
+8.11%
Jun 30, 2025
Silvercrest Asset Management Group LLC
851.95K
2.75%
-183.66K
-17.73%
Jun 30, 2025
Capital Research Global Investors
1.68M
5.41%
+2.76K
+0.16%
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
State Street SPDR S&P Health Care Equipment ETF
1.48%
ROBO Global Healthcare Technology & Innovation ETF
1.05%
Invesco S&P SmallCap Health Care ETF
0.83%
Harbor Human Capital Factor US Small Cap ETF
0.56%
First Trust Small Cap Value AlphaDEX Fund
0.49%
VictoryShares Small Cap Free Cash Flow ETF
0.36%
WisdomTree US SmallCap Quality Dividend Growth
0.24%
First Trust Small Cap Core Alphadex Fund
0.24%
Lattice Hartford Multifactor Small Cap ETF
0.23%
Franklin US Small Cap Multifactor Index ETF
0.2%
詳細を見る
State Street SPDR S&P Health Care Equipment ETF
比率1.48%
ROBO Global Healthcare Technology & Innovation ETF
比率1.05%
Invesco S&P SmallCap Health Care ETF
比率0.83%
Harbor Human Capital Factor US Small Cap ETF
比率0.56%
First Trust Small Cap Value AlphaDEX Fund
比率0.49%
VictoryShares Small Cap Free Cash Flow ETF
比率0.36%
WisdomTree US SmallCap Quality Dividend Growth
比率0.24%
First Trust Small Cap Core Alphadex Fund
比率0.24%
Lattice Hartford Multifactor Small Cap ETF
比率0.23%
Franklin US Small Cap Multifactor Index ETF
比率0.2%
配当金
過去5年間の配当金総支払額は
119.19M
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Aug 08, 2025
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 03, 2025 going ex on Sep 15, 2025
Sep 15, 2025
Oct 03, 2025
Sep 15, 2025
May 21, 2025
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 03, 2025 going ex on Jun 13, 2025
Jun 13, 2025
Jul 03, 2025
Jun 13, 2025
Feb 25, 2025
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 04, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 04, 2025
Mar 14, 2025
Dec 10, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 03, 2025 going ex on Dec 20, 2024
Dec 20, 2024
Jan 03, 2025
Dec 20, 2024
Aug 09, 2024
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 04, 2024 going ex on Sep 16, 2024
Sep 16, 2024
Oct 04, 2024
Sep 16, 2024
May 22, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 05, 2024
Jun 14, 2024
Feb 26, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 05, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 05, 2024
Mar 14, 2024
Dec 05, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 05, 2024 going ex on Dec 15, 2023
Dec 18, 2023
Jan 05, 2024
Dec 15, 2023
Aug 10, 2023
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 05, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 05, 2023
Sep 14, 2023
May 24, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 05, 2023
Jun 14, 2023
詳細を見る
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
よくある質問
Conmed Corpの上位5名の株主は誰ですか？
Conmed Corpの上位5名の株主は以下のとおりです。
BlackRock Institutional Trust Company, N.A.は4.43M株を保有しており、これは全体の14.30%に相当します。
The Vanguard Group, Inc.は3.54M株を保有しており、これは全体の11.44%に相当します。
EARNEST Partners, LLCは2.83M株を保有しており、これは全体の9.14%に相当します。
Fuller & Thaler Asset Management Inc.は1.74M株を保有しており、これは全体の5.62%に相当します。
Westwood Management Corp. (Texas)は1.24M株を保有しており、これは全体の4.00%に相当します。
BlackRock Institutional Trust Company, N.A.は4.43M株を保有しており、これは全体の14.30%に相当します。
The Vanguard Group, Inc.は3.54M株を保有しており、これは全体の11.44%に相当します。
EARNEST Partners, LLCは2.83M株を保有しており、これは全体の9.14%に相当します。
Fuller & Thaler Asset Management Inc.は1.74M株を保有しており、これは全体の5.62%に相当します。
Westwood Management Corp. (Texas)は1.24M株を保有しており、これは全体の4.00%に相当します。
Conmed Corpの株主タイプ上位3種は何ですか？
Conmed Corpの株主タイプ上位3種は、
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
EARNEST Partners, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
EARNEST Partners, LLC
Conmed Corp（CNMD）の株式を保有している機関の数はいくつですか？
2025Q4時点で、Conmed Corpの株式を保有している機関は638社あり、保有株式の総市場価値は約36.30Mで、全体の136.51%を占めています。2025Q3と比較して、機関の持ち株は-0.81%増加しています。
Conmed Corpの最大の収益源は何ですか？
FY2025Q2において、General Surgery部門がConmed Corpにとって最大の収益を生み出しており、その金額は201.61Mで、全収益の58.89%を占めています。
